Cargando…

Immunogenicity of recombinant VP2 proteins of all nine serotypes of African horse sickness virus

African horse sickness (AHS) is an equine disease with a mortality of up to 90% for susceptible horses. The causative agent AHS virus (AHSV) is transmitted by species of Culicoides. AHSV serogroup within the genus Orbivirus of the Reoviridae family consists of nine serotypes that show no or very lim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kanai, Yuta, van Rijn, Piet A., Maris-Veldhuis, Mieke, Kaname, Yuki, Athmaram, T.N., Roy, Polly
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4148702/ https://www.ncbi.nlm.nih.gov/pubmed/25045805 http://dx.doi.org/10.1016/j.vaccine.2014.07.031

Ejemplares similares

Pentavalent Disabled Infectious Single Animal (DISA)/DIVA Vaccine Provides Protection in Sheep and Cattle against Different Serotypes of Bluetongue Virus
por: van Rijn, Piet A., et al.
Publicado: (2021)

Bluetongue Viruses Based on Modified-Live Vaccine Serotype 6 with Exchanged Outer Shell Proteins Confer Full Protection in Sheep against Virulent BTV8
por: van Gennip, René G. P., et al.
Publicado: (2012)

The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host
por: Calvo-Pinilla, Eva, et al.
Publicado: (2018)

African Horse Sickness Virus Serotype 1 on Horse Farm, Thailand, 2020
por: Bunpapong, Napawan, et al.
Publicado: (2021)

Assembly of Replication-Incompetent African Horse Sickness Virus Particles: Rational Design of Vaccines for All Serotypes
por: Lulla, Valeria, et al.
Publicado: (2016)

VP2 Exchange and NS3/NS3a Deletion in African Horse Sickness Virus (AHSV) in Development of Disabled Infectious Single Animal Vaccine Candidates for AHSV
por: van de Water, Sandra G. P., et al.
Publicado: (2015)

Safety and immunogenicity of plant-produced African horse sickness virus-like particles in horses
por: Dennis, Susan J., et al.
Publicado: (2018)

Assessment of reproducibility of a VP7 Blocking ELISA diagnostic test for African horse sickness
por: Durán‐Ferrer, Manuel, et al.
Publicado: (2018)

The Bluetongue Disabled Infectious Single Animal (DISA) Vaccine Platform Based on Deletion NS3/NS3a Protein Is Safe and Protective in Cattle and Enables DIVA
por: van Rijn, Piet A., et al.
Publicado: (2021)

B-cell epitopes of African horse sickness virus serotype 4 recognised by immune horse sera
por: Mathebula, Evans M., et al.
Publicado: (2017)

Comparative immune responses after vaccination with the formulated inactivated African horse sickness vaccine serotype 1 between naïve horses and pretreated horses with the live-attenuated African horse sickness vaccine
por: Chaiyabutr, Narongsak, et al.
Publicado: (2022)

Entry-competent-replication-abortive African horse sickness virus strains elicit robust immunity in ponies against all serotypes
por: Sullivan, Edward, et al.
Publicado: (2021)

Investigating the Role of African Horse Sickness Virus VP7 Protein Crystalline Particles on Virus Replication and Release
por: Bekker, Shani, et al.
Publicado: (2022)

Horse Sickness
por: Smith, W. Ramsey
Publicado: (1902)

Requirements and comparative analysis of reverse genetics for bluetongue virus (BTV) and African horse sickness virus (AHSV)
por: van Rijn, Piet A., et al.
Publicado: (2016)

Generation of a Soluble African Horse Sickness Virus VP7 Protein Capable of Forming Core-like Particles
por: Bekker, Shani, et al.
Publicado: (2022)

Codon Optimization, Expression in Escherichia coli, and Immunogenicity of Recombinant Chinese Sacbrood Virus (CSBV) Structural Proteins VP1, VP2, and VP3
por: Fei, Dongliang, et al.
Publicado: (2015)

Clinical, Virological and Immunological Responses after Experimental Infection with African Horse Sickness Virus Serotype 9 in Immunologically Naïve and Vaccinated Horses
por: Durán-Ferrer, Manuel, et al.
Publicado: (2022)

A Heat-Induced Mutation on VP1 of Foot-and-Mouth Disease Virus Serotype O Enhanced Capsid Stability and Immunogenicity
por: Dong, Hu, et al.
Publicado: (2021)

Evidence of Intragenic Recombination in African Horse Sickness Virus
por: Ngoveni, Harry G., et al.
Publicado: (2019)

Correction: Codon Optimization, Expression in Escherichia coli, and Immunogenicity of Recombinant Chinese Sacbrood Virus (CSBV) Structural Proteins VP1, VP2, and VP3
por: Fei, Dongliang, et al.
Publicado: (2015)

Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge
por: Alberca, Berta, et al.
Publicado: (2014)

Protective efficacy of multivalent replication-abortive vaccine strains in horses against African horse sickness virus challenge
por: Lulla, Valeria, et al.
Publicado: (2017)

Immunogenicity of plant‐produced African horse sickness virus‐like particles: implications for a novel vaccine
por: Dennis, Susan J., et al.
Publicado: (2017)

A single dose of African horse sickness virus (AHSV) VP2 based vaccines provides complete clinical protection in a mouse model
por: Aksular, Mine, et al.
Publicado: (2018)

Immune response of horses to inactivated African horse sickness vaccines
por: Rodríguez, Marina, et al.
Publicado: (2020)

Development of Differentiating Infected from Vaccinated Animals (DIVA) Real-Time PCR for African Horse Sickness Virus Serotype 1
por: Wang, Yifan, et al.
Publicado: (2022)

Characterization of Protection Afforded by a Bivalent Virus-Like Particle Vaccine against Bluetongue Virus Serotypes 1 and 4 in Sheep
por: Pérez de Diego, Ana Cristina, et al.
Publicado: (2011)

Construction, Expression and Evaluation of Recombinant VP2 Protein for serotype-independent Detection of FMDV Seropositive Animals in Egypt
por: Salem, Reda, et al.
Publicado: (2019)

Serotype Specific Primers and Gel-Based RT-PCR Assays for ‘Typing’ African Horse Sickness Virus: Identification of Strains from Africa
por: Maan, Narender S., et al.
Publicado: (2011)

The Genomic Makeup of Nine Horse Populations Sampled in the Netherlands
por: Schurink, Anouk, et al.
Publicado: (2019)

The Construction and Immunogenicity Analyses of a Recombinant Pseudorabies Virus with Senecavirus A VP2 Protein Coexpression
por: Tao, Qian, et al.
Publicado: (2023)

Antigenicity and Immunogenicity Analysis of the E. coli Expressed FMDV Structural Proteins; VP1, VP0, VP3 of the South African Territories Type 2 Virus
por: Li, Guoxiu, et al.
Publicado: (2021)

Ns1 Is a Key Protein in the Vaccine Composition to Protect Ifnar(−/−) Mice against Infection with Multiple Serotypes of African Horse Sickness Virus
por: de la Poza, Francisco, et al.
Publicado: (2013)

Sequencing of the VP1–2A Genome Segment for Hepatitis A Subtyping
por: Zalesskikh, A.A., et al.
Publicado: (2020)

A novel recombinant pseudorabies virus expressing parvovirus VP2 gene: Immunogenicity and protective efficacy in swine
por: Chen, Yang, et al.
Publicado: (2011)

A Modified Vaccinia Ankara Virus (MVA) Vaccine Expressing African Horse Sickness Virus (AHSV) VP2 Protects Against AHSV Challenge in an IFNAR −/− Mouse Model
por: Castillo-Olivares, Javier, et al.
Publicado: (2011)

Structure based modification of Bluetongue virus helicase protein VP6 to produce a viable VP6-truncated BTV
por: Matsuo, Eiko, et al.
Publicado: (2014)

Antigenicity and Immunogenicity of Rotavirus VP6 Protein Expressed on the Surface of Lactococcus lactis
por: Esteban, L. E., et al.
Publicado: (2013)

Immunogenicity of recombinant Lactobacillus plantarum NC8 expressing goose parvovirus VP2 gene in BALB/c mice
por: Liu, Yu-Ying, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_p6mvpcv97r06j7vm618mq7qqcs